Skip to main content

Table 4 Phenotypical analysis of α -type-1 DCs after a 7-day culture

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Markers Frequency (%)* Markers Frequency (%) Markers Frequency (%)
CD1a 16.3±13.2 CD80 92.4±15.5 CMRF44 3.7±2.4
CD11c 99.3±0.6 CD83 44.7±19.5 CMRF56 37.1±11.2
CD33 7.0±3.8 CD86 99.6±0.3 E-cadherin 13.1±7.4
CD40 95.9±5.1 CD205 73.9±12.1 CCR7 6.0±1.9
CD54 99.3±1.2 CD207 92.3±11.6 HLA-class I 99.0±1.2
  1. * Each value represents the frequency of marker-positive cells in lineage-HLA-DR+ gated population.